A new study in Israel has revealed that a third dose of the Pfizer Inc.–BioNTech SE Covid vaccine can dramatically reduce rates of Covid-related illness in people 60 and older. This is good news for the fight against the covid-19 pandemic.
Starting 12 days after the extra dose, confirmed infection rates were 11 times lower in the booster group compared with a group that got the standard two doses, the analysis released Wednesday by the New England Journal of Medicine found. Rates of severe illness were almost 20 times lower in the booster group.
Vaccination Mandates are Here to Stay: All International Travellers to the US from Nov 8th Required to be fully Vaccinated
Nokia and TPG Telecom deploy Asia Pacific’s first live 5G femtocell
Facebook Continues to Rise and this is Why
Covid-19 on the Decline in South Africa: Lockdown Level 2 imminent, with new curfew, booze and gathering rules expected
Insight into South African Entrepreneur
Counting the Cost of the South African Riot: Food Shortage is Here
Economy1 month ago
White Striping Disease Hits 99% of U.S. Supermarket Chicken, Study Finds
Global1 month ago
iPhone 13 is Here: Apple Launches iPhone 13 With Camera, Chip and Screen Upgrades
News1 month ago
A Blow to “Thuma Mina” as Study Shows Corruption ‘worsening’ during Ramaphosa’s tenure
Covid-191 month ago
Vaccinated Foreigners Welcome to the U.S.